OM1 introduces three new products: OM1 Orion, OM1 Lyra, and OM1 Polaris powered by PhenOMTM – an artificial intelligence-powered digital phenotyping platform for personalized medicine and clinical r...
The company is introducing OM1 Orion, OM1 Lyra, and OM1 Polaris, aligning AI technology and real-world data to offer unprecedented insights into the patient journey and further patient outcomes through prediction, precision, and discovery
BOSTON: OM1 introduces three new products: OM1 Orion, OM1 Lyra, and OM1 Polaris powered by PhenOMTM – an artificial intelligence-powered digital phenotyping platform for personalized medicine and clinical research. OM1 is the leader in providing Real-World Evidence (RWE) insights from bench to bedside, leveraging advanced predictive and generative AI platforms coupled with deep clinical data to empower healthcare stakeholders.
Today’s healthcare landscape is plagued with disparate and disconnected data sources, resulting in large, critical knowledge gaps from research and development to point-of-care clinical decision-making. Standing at the forefront of innovative predictive and generative AI-powered solutions, OM1 PhenOM’s products deliver unparalleled insights to empower HCP decision support for point-of-care treatment, close gaps in patient journeys by leveraging complex phenotyping models over deep clinical big data, and locate hard-to-find patient populations for research and treatment.
“There is a tremendous untapped opportunity to synthesize data sources to better understand patient journeys and treatment decisions, which we've learned to address with our digital phenotyping technology," said Joseph Zabinski, VP, Head of Commercial Strategy & AI at OM1. “Now, with our expanded product offerings, we can identify patients to reveal hidden characteristics and predict outcomes, ultimately improving how we conduct research and deliver care.”
Launched last year, PhenOM is built on OM1’s differentiated, high-quality data cloud – based on billions of data points from more than 340+ million patients – to improve individual care and population health. Now, with its distinct product lines, the platform delivers unmatched next-gen AI technology and clinically robust real-world data to address critical pain points across the healthcare ecosystem:
“In a world of AI hype and skepticism, OM1’s Lyra, Orion, and Polaris solutions are a lighthouse for harnessing incredibly advanced technologies to empower providers and patients to truly own their personal journeys and to receive the ideal support from all healthcare stakeholders who share the common goal of advancing care for superior outcomes. Our leadership in this space aims to strengthen the relationship between a patient and their provider while improving the standard of care,” said Shawn Bates, Chief Commercial Officer at OM1.
To learn more about OM1’s real-world data and patented AI technology, please email info@om1.com.
About OM1
OM1 is pioneering cutting-edge healthcare innovation through its insights-driven technology and data. It specializes in personalized medicine, evidence generation, and real-world evidence (RWE) research powered by next-generation AI platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. OM1 is led by a diverse group of scientists, engineers, researchers, and clinicians with over 30 years of experience in RWD/RWE who have written the handbook on building clinical registries and developing the outcomes measure framework. OM1’s unprecedented innovation takes RWE from bench to practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research.
Fonte: Business Wire
The Italian company partners with MainStreaming for high-performance, energy-efficient video streaming
Software vendors developing vertical solutions against specific attack vectors are 'cool' again. And when it comes to email security, all companies now…
Links Management and Technology just concluded the testing phase of a research project focused on banking transformation
Axyon AI offers an AI platform specifically designed for asset management, with several interesting strengths for those approaching machine/deep learning…
Transact Campus, (“Transact”) the award winning leader in innovative mobile credential and payment solutions for a connected campus, today announced the…
Emburse, whose innovative travel and expense (T&E) solutions power forward-thinking organizations, today launched survey findings revealing an even…
$KEYS #5G--Keysight Technologies, Inc. (NYSE: KEYS) announces that the University of Malaga, specifically the MobileNet: Mobile & Aerospace Networks…
Emburse, whose leading travel and expense solutions power forward-thinking organizations, continues its innovative track record by unveiling its vision…